Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 103
- Press releases
Ananda Developments Signs MOU With Nottingham Trent University
Ananda Developments plc (AQSE: ANA)and its wholly owned subsidiary DJT Plants Limited (“DJT”) have signed a Memorandum of Understanding (“MOU”) with Nottingham Trent University (“NTU”) to pursue third-party grant funding to progress DJT’s medical cannabis breeding programme and its low carbon medical cannabis cultivation and manufacturing.
- Uncategorized
Business of Cannabis: New York, 2023
Business of Cannabis: New York 2023 kicked off this morning in the New York Academy of Medicine, bringing together hundreds of the state’s key cannabis regulators, policy makers, financial institutions and leading businesses.
- Press releases
Your Medicinal Cannabis Companion Arrives
Canndr® Debuts at The 2023 UK Medicinal Cannabis Awareness Week, the patient-centric platform powered by patients who deserve clarity, information and protection of their rights.
- Uncategorized
Sorting Robotics Secures $2 Million in Debt Financing to Accelerate Cannabis Industry Automation
Sorting Robotics, a provider of industrial automation solutions in the cannabis sector, has successfully secured $2 million in debt financing.
- Medical
France’s Government Takes Major Step Towards Medical Cannabis Generalisation
Following months of uncertainty and doubt, thousands of medical cannabis patients in France can now breathe a sigh of relief after the government finally confirmed that access to their treatment will continue.
- Press releases
British Cannabis Announces New Partnership With Kanabo
Kanabo Group plc (LSE: KNB), the patient-focused provider of digital health services and specialist medicines, including medicinal cannabis, is pleased to announce that it has entered into a partnership with BRITISH CANNABIS™ to supply the CBD by BRITISH CANNABIS™ range of pharmacy-grade CBD health supplements to patients via a prescription service through the Group’s online…
- Markets & Stocks
MGC Pharma & Hellenic Dynamics Both Turn to Share Consolidation as They Secure New Funding, Stenocare Celebrates ‘Milestone’ Launch into Germany
MGC Pharmaceuticals [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”MXC.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] MGC Pharmaceuticals announced this week that it has now secured ‘binding commitments’ for US$7.9m in investment, which the company says will be enough to fund its business plan over the next 12-months.
- CBD Market
Italy’s CBD Ban Suspended Until January, Switzerland Approves 6th Adult-Use Trial, & Malta’s First Cannabis Clubs to Launch in Q1 2024
Italy’s CBD ban pushed back further by court Last week, Italy’s Regional Administrative Court of Lazio (TAR) confirmed its position, ruling in favour of suspending a decree that would make CBD oil a narcotic substance until January 16, 2024.
- Uncategorized
‘Once Customers Learn About This Amazing New Legal Market in New York, They Don’t Go Back to Shopping at Illicit Stores’
Ahead of her appearance at Business of Cannabis: New York at the end of the week (November 03), we caught up with Arana Hankin Biggers, CEO of Union Square Travel Agency, to discuss the importance of the CAURD programme, and how its been to be one of the first legal cannabis dispensaries in the state.
- Press releases
UK Medical Cannabis Imports Have Tripled in Size This Year
November 01 this year marks five years since the UK government legalised cannabis-based products for medicinal use in 2018 and figures released by the Home Office this week have shown that the amount of medical cannabis imported has tripled in volume this year.
- Uncategorized
Nevada Cannabis Authority Approves 6 New Conditional Consumption Lounge Licences
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at the New York Academy of Medicine.
- Press releases
Cantourage Group SE Launches a Range of High-THC Medicinal Cannabis Flowers in Switzerland Together With Astrasana
Cantourage Group SE (hereinafter “Cantourage,” ISIN: DE000A3DSV01, www.cantourage.com), a leading European company for the production and distribution of medical cannabis, has signed a long-term supply agreement for medical cannabis with the Swiss cannabis company Astrasana.











